Focused Wealth Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$214K Buy
3,337
+432
+15% +$28.4K 0.02% 227
2026
Q1
$207K Sell
2,905
-20
-0.7% -$1.58K 0.02% 191
2025
Q4
$240K Sell
2,925
-134
-4% -$10.4K 0.03% 159
2025
Q3
$230K Buy
3,059
+62
+2% +$4.62K 0.02% 170
2025
Q2
$222K Buy
2,997
+1
+0% +$70 0.03% 164
2025
Q1
$242K Sell
2,996
-75
-2% -$6.45K 0.03% 145
2024
Q4
$240K Sell
3,071
-85
-3% -$7.22K 0.03% 137
2024
Q3
$296K Sell
3,156
-7
-0.2% -$588 0.04% 155
2024
Q2
$246K Sell
3,163
-54
-2% -$4.41K 0.04% 157
2024
Q1
$292K Sell
3,217
-258
-7% -$21.5K 0.04% 126
2023
Q4
$269K Sell
3,475
-60
-2% -$4.2K 0.04% 114
2023
Q3
$241K Sell
3,535
-48
-1% -$3.49K 0.04% 123
2023
Q2
$291K Sell
3,583
-104
-3% -$8.3K 0.05% 109
2023
Q1
$302K Buy
+3,687
New +$263K 0.06% 103

Other funds holding GEHC

Focused Wealth Management's GEHC Position: Q2 2026 in Review

Focused Wealth Management increased its GE HealthCare (GEHC) stake by 15% in Q2 2026, buying an estimated $28.4K and bringing the position to 3,337 shares worth $214K. The position accounts for 0.02% of the portfolio, ranked #227.

Focused Wealth Management first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $302K in Q1 2023. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Focused Wealth Management held 3,337 shares of GE HealthCare worth $214K as of Q2 2026.
  • Focused Wealth Management bought 432 GE HealthCare shares in Q2 2026, an estimated $28.4K.
  • GE HealthCare made up 0.02% of Focused Wealth Management's portfolio in Q2 2026, its #227 holding.
  • Focused Wealth Management first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Focused Wealth Management's GE HealthCare position peaked at $302K in Q1 2023.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Focused Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.